The 10-year Treasury now pays 5.31%, and most dividend stocks simply cannot clear that bar.
Omega Healthcare Investors is downgraded from buy to hold as growth appears fully priced in near current levels. OHI delivered strong Q2 results, with AFFO guidance raised to $3.22–$3.26 and a 4.2% growth rate amid challenging conditions. Balance sheet strength is notable, with net debt to EBITDA at 3.3x and an 87% FAD payout ratio supporting a secure 5.71% dividend yield.
Omega Healthcare remains Buy rated, offering a near 6% yield and structural advantages in skilled nursing real estate. OHI's upcoming earnings are expected to be quietly strong, with AFFO/share modeled at $0.81 versus the Street's $0.80. Recent acquisitions and stable rental income support 4% y/y revenue growth, while interest expense and G&A remain contained.
The leading edge of 70 million baby boomers just started turning 80, and new senior housing construction sits at record lows.
Omega Healthcare Investors (OHI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Omega Healthcare Investors NYSE: OHI reported second-quarter 2026 results marked by higher revenue, a large gain from asset sales, improved portfolio coverage and an increased full-year Adjusted FFO outlook, while management outlined plans for greater investment activity in the second half of the year.
Omega Healthcare Investors, Inc. (OHI) Q2 2026 Earnings Call Transcript
Omega Healthcare Investors is now rated Hold as its valuation aligns with fair value, reflecting a balanced risk-reward profile. OHI's SHOP/RIDEA operational pivot positions it to capture upside from demographic tailwinds but introduces greater operational risk and volatility. Q2 results showed AFFO up 12.55% YoY, a dividend increase after years of pause, and upgraded 2026 AFFO guidance to $3.22–$3.26 per share.
Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.83 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to FFO of $0.77 per share a year ago.
Omega Healthcare Investors (OHI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Omega Healthcare Investors is downgraded from bullish to neutral as valuation now reflects its recovery and growth prospects. OHI's dividend is well covered, with payout ratios at 82% of AFFO and 86% of FAD, and management hints at a possible raise in 2027. Active portfolio management, capital recycling, and a strategic pivot toward RIDEA and senior housing are driving operational improvements and future growth potential.
Omega Healthcare Investors offers a compelling high-yield opportunity after a recent price pullback, now yielding over 6%. OHI's fundamentals are robust, with FAD per share up 9.5% YoY, improved dividend coverage at 86%, and tenant rent coverage at a decade high. Strategic expansion into RIDEA structures and value-added acquisitions positions OHI for potentially strong total returns.